申请人:THE REGENTS OF THE UNIVERSITY OF MICHIGAN
公开号:US11168082B2
公开(公告)日:2021-11-09
The present disclosure provides compounds represented by Formula I and II: and the pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, X, W, Y, and Z are as defined as set forth in the specification. The present disclosure also provides compounds of Formula I and II for use to treat a condition or disorder responsive to LSD1 inhibition such as cancer.
本公开提供了式 I 和 II 所代表的化合物:及其药学上可接受的盐和溶液,其中 R1、R2、R3、X、W、Y 和 Z 如说明书中所定义。本公开还提供了式 I 和 II 的化合物,用于治疗对 LSD1 抑制有反应的病症或紊乱,如癌症。